Navigation Links
Quick identification needed to save Florida's citrus industry from devastating disease

The recent discovery of citrus greening (huanglongbing) in samples collected from trees in South Florida poses a definite threat to Florida's $9 billion commercial citrus industry. Proper identification and eradication methods are needed to reduce the amount of crop loss caused by this disease, say plant pathologists with The American Phytopathological Society (APS). Citrus greening is a bacterial disease that affects the phloem system of citrus plants causing the infected trees to yellow, decline, and possibly die within a few years. The bacterium is spread by an insect, the citrus psyllid.

"Although there is no cure for citrus greening, it is vital that plant pathologists work with growers to quickly identify the disease and its insect hosts," said Ronald Brlansky, professor and plant pathologist with the University of Florida, CREC, Lake Alfred, FL. "Finding the extent of the disease and the removal of infected trees will reduce the damage done by this disease," he said. Plant pathologists have been surveying and testing for citrus greening since the psyllids were found in the U.S. in the late 1990s.

Citrus greening infects all types of citrus species. The name "huanglongbing" means "yellow dragon" which is descriptive of the yellow sectors of infected trees. The symptoms of citrus greening usually include a blotchy mottle and leaf yellowing that spreads throughout the tree with lopsided fruit that fail to color properly.

Citrus greening has seriously affected citrus production in Asia, Africa, the Indian subcontinent and the Arabian Peninsula, and was recently discovered in Brazil.


'"/>

Source:American Phytopathological Society


Page: 1

Related biology news :

1. Quick -- what’s that smell?
2. Researchers develop rapid diagnostic tool for pathogen identification
3. Product improves peptide identification for proteomics research
4. Researchers develop new method for facile identification of proteins in bacterial cells
5. World Trade Center identifications pushed forensic DNA technology
6. Genomatix technology facilitates de novo identification of new renal disease associated genes
7. Scientists create dual-modality microbeads to improve identification of disease biomarkers
8. Automatic identification of proteins critical features from the structure
9. A much-needed shot in the arm for HIV vaccine development
10. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
11. Clear rules needed to govern deep sea bioprospecting: UNU
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology: